Completed
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea
NCT01150942
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea